Advertisement
UK markets open in 1 hour 57 minutes

  • NIKKEI 225

    39,108.74
    +491.64 (+1.27%)
     

  • HANG SENG

    18,930.02
    -265.58 (-1.38%)
     

  • CRUDE OIL

    77.03
    -0.54 (-0.70%)
     

  • GOLD FUTURES

    2,374.80
    -18.10 (-0.76%)
     

  • DOW

    39,671.04
    -201.95 (-0.51%)
     

  • Bitcoin GBP

    54,619.85
    -63.92 (-0.12%)
     

  • CMC Crypto 200

    1,515.30
    -11.12 (-0.73%)
     

  • NASDAQ Composite

    16,801.54
    -31.08 (-0.18%)
     

  • UK FTSE All Share

    4,560.55
    -23.85 (-0.52%)
     
Money:

How to protect your finances during divorce

However you do it divorce will leave you poorer, and you will need to watch your finances carefully

STOCKS NEWS EUROPE-Galapagos at 8-month high as UBS rates "buy"

Reuters - UK Focus

Shares in Galapagos (Other OTC: GLPGF - news) rise 4.8 percent to their highest level since May 2013 and the top of Belgium's mid-cap Bel Mid index, with traders highlighting that analysts at UBS (Xetra: UB0BL6 - news) have started coverage of the biotech group with a "buy" rating.

Volume on the stock, which trades at 17.80 euros, is already over half of its full day average for the past three months at 0835 GMT.

UBS, which sets a target price of 21 euros for the shares, says that the group's large pipeline of medical trials could produce positive news over the coming 12 to 24 months.

"Success (Shenzhen: 002289.SZ - news) of the cystic fibrosis project could create 144 percent upside, and all other projects could yield 30-65 percent upside each," UBS writes in a note to clients. Reuters messaging rm://robertjan.bartunek.thomsonreuters.com@reuters.net